These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 7536073

  • 1. Pilot trial of combined administration of erythropoietin and granulocyte colony-stimulating factor to children undergoing allogeneic bone marrow transplantation.
    Locatelli F, Zecca M, Ponchio L, Beguin Y, Giorgiani G, Maccario R, Bonetti F, De Stefano P, Cazzola M.
    Bone Marrow Transplant; 1994 Dec; 14(6):929-35. PubMed ID: 7536073
    [Abstract] [Full Text] [Related]

  • 2. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial.
    Vannucchi AM, Bosi A, Ieri A, Guidi S, Saccardi R, Lombardini L, Linari S, Laszlo D, Longo G, Rossi-Ferrini P.
    Bone Marrow Transplant; 1996 Apr; 17(4):527-31. PubMed ID: 8722349
    [Abstract] [Full Text] [Related]

  • 4. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
    Vannucchi AM, Bosi A, Linari S, Guidi S, Longo G, Lombardini L, Mariani MP, Saccardi R, Laszlo D, Rossi Ferrini P.
    Haematologica; 1997 Apr; 82(1):53-6. PubMed ID: 9107083
    [Abstract] [Full Text] [Related]

  • 5. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
    Locatelli F, Pession A, Zecca M, Bonetti F, Prete L, Carrà AM, Prete A, Montagna D, Comoli P, Taibi RM, Paolucci G.
    Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051
    [Abstract] [Full Text] [Related]

  • 6. Granulocyte-colony-stimulating factor after allogeneic and autologous bone marrow transplantation in children.
    Saarinen UM, Hovi L, Juvonen E, Riikonen P, Möttönen M, Mäkipernaa A.
    Med Pediatr Oncol; 1996 Jun; 26(6):380-6. PubMed ID: 8614373
    [Abstract] [Full Text] [Related]

  • 7. Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants.
    Locatelli F, Zecca M, Pedrazzoli P, Prete L, Quaglini S, Comoli P, De Stefano P, Beguin Y, Robustelli della Cuna G, Severi F.
    Bone Marrow Transplant; 1994 Apr; 13(4):403-10. PubMed ID: 8019464
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phase II study of recombinant human granulocyte colony-stimulating factor in children undergoing bone marrow transplantation.
    Dini G, Floris R, Pession A, Manfredini L, Dallorso S, Lanino E, Garaventa A, Miano M, Kotitsa Z, Rondelli R.
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():121-8. PubMed ID: 8932813
    [Abstract] [Full Text] [Related]

  • 10. Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantation.
    Pene R, Appelbaum FR, Fisher L, Lilleby K, Nemunaitis J, Storb R, Buckner CD.
    Bone Marrow Transplant; 1993 Mar; 11(3):219-22. PubMed ID: 8467286
    [Abstract] [Full Text] [Related]

  • 11. Clinical benefits of granulocyte colony-stimulating factor therapy after hematopoietic stem cell transplant in children: results of a prospective randomized trial.
    Dallorso S, Rondelli R, Messina C, Pession A, Giorgiani G, Fagioli F, Locatelli F, Manzitti C, Balduzzi A, Prete A, Cesaro S, Lanino E, Dini G.
    Haematologica; 2002 Dec; 87(12):1274-80. PubMed ID: 12495901
    [Abstract] [Full Text] [Related]

  • 12. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F.
    J Clin Oncol; 2004 Feb 01; 22(3):416-23. PubMed ID: 14691124
    [Abstract] [Full Text] [Related]

  • 13. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM, Bierman PJ, Ruby E, Reed EC, Bishop MR, Tarantolo S, Kessinger A, Armitage JO.
    Bone Marrow Transplant; 1996 Jun 01; 17(6):951-6. PubMed ID: 8807099
    [Abstract] [Full Text] [Related]

  • 14. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF.
    Isola LM, Scigliano E, Skerrett D, Shank B, Ross V, Najfeld V, Fruchtman S.
    Bone Marrow Transplant; 1997 Dec 01; 20(12):1033-7. PubMed ID: 9466275
    [Abstract] [Full Text] [Related]

  • 15. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates engraftment kinetics after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia.
    Madero L, Díaz MA, Ortega JJ, Olive T, Martínez A, Badell I, Muñoz A, Gómez P.
    Haematologica; 1999 Feb 01; 84(2):133-7. PubMed ID: 10091411
    [Abstract] [Full Text] [Related]

  • 16. Combined use of erythropoietin and granulocyte colony-stimulating factor does not decrease blood transfusion requirements during induction therapy for high-risk neuroblastoma: a randomized controlled trial.
    Wagner LM, Billups CA, Furman WL, Rao BN, Santana VM.
    J Clin Oncol; 2004 May 15; 22(10):1886-93. PubMed ID: 15143081
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
    Schmitz N, Dreger P, Zander AR, Ehninger G, Wandt H, Fauser AA, Kolb HJ, Zumsprekel A, Martin A, Hecht T.
    Bone Marrow Transplant; 1995 Feb 15; 15(2):261-6. PubMed ID: 7539668
    [Abstract] [Full Text] [Related]

  • 19. Granulocyte-macrophage colony-stimulating factor after autologous marrow transplantation for Hodgkin's disease.
    Klingemann HG, Wilkie-Boyd K, Rubin A, Onetto N, Nantel SH, Barnett MJ, Reece DE, Shepherd JD, Phillips GL.
    Biotechnol Ther; 1994 Feb 15; 5(1-2):1-13. PubMed ID: 7703829
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.